Redhill Biopharma
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-09-30 |
|---|---|---|
Revenue | $2,735 | $2,735 |
Gross Profit | 1,841 | 1,841 |
EBITDA | -1,878 | -1,817 |
EBIT | -1,903 | -1,903 |
Net Income | -2,590 | -2,590 |
Net Change In Cash | 2,735 | 2,735 |
Free Cash Flow | -1,596 | -1,596 |
Cash | 4,617 | 1,882 |
Basic Shares | 2,576 | 2,576 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $8,043 | $6,530 | $61,800 | $85,757 |
Gross Profit | 4,851 | 3,071 | 28,463 | 36,351 |
EBITDA | -7,594 | 26,273 | -22,182 | -63,028 |
EBIT | -8,213 | 24,283 | -30,336 | -81,177 |
Net Income | -8,268 | 23,916 | -71,669 | -97,744 |
Net Change In Cash | 8,043 | 6,530 | 61,800 | 85,757 |
Free Cash Flow | -9,378 | -35,831 | -29,383 | -65,162 |
Cash | 4,617 | 5,569 | 19,968 | 29,474 |
Basic Shares | 2,464 | 518 | 123 | 93 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$2.29 |
2025-03-31 | -$4.02 |
2024-12-31 | -$4.02 |
